243 related articles for article (PubMed ID: 23128397)
1. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.
Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R
Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397
[TBL] [Abstract][Full Text] [Related]
2. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
[TBL] [Abstract][Full Text] [Related]
4. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
[TBL] [Abstract][Full Text] [Related]
5. H4K20me3 co-localizes with activating histone modifications at transcriptionally dynamic regions in embryonic stem cells.
Xu J; Kidder BL
BMC Genomics; 2018 Jul; 19(1):514. PubMed ID: 29969988
[TBL] [Abstract][Full Text] [Related]
6. Bivalent Histone Modifications and Development.
Li F; Wan M; Zhang B; Peng Y; Zhou Y; Pi C; Xu X; Ye L; Zhou X; Zheng L
Curr Stem Cell Res Ther; 2018; 13(2):83-90. PubMed ID: 28117006
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
8. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
9. Bivalent Histone Codes on WNT5A during Odontogenic Differentiation.
Zhou Y; Zheng L; Li F; Wan M; Fan Y; Zhou X; Du W; Pi C; Cui D; Zhang B; Sun J; Zhou X
J Dent Res; 2018 Jan; 97(1):99-107. PubMed ID: 28880717
[TBL] [Abstract][Full Text] [Related]
10. Chromatin signature of embryonic pluripotency is established during genome activation.
Vastenhouw NL; Zhang Y; Woods IG; Imam F; Regev A; Liu XS; Rinn J; Schier AF
Nature; 2010 Apr; 464(7290):922-6. PubMed ID: 20336069
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide positioning of bivalent mononucleosomes.
Sen S; Block KF; Pasini A; Baylin SB; Easwaran H
BMC Med Genomics; 2016 Sep; 9(1):60. PubMed ID: 27634286
[TBL] [Abstract][Full Text] [Related]
12. A low-input high resolution sequential chromatin immunoprecipitation method captures genome-wide dynamics of bivalent chromatin.
Seneviratne JA; Ho WWH; Glancy E; Eckersley-Maslin MA
Epigenetics Chromatin; 2024 Feb; 17(1):3. PubMed ID: 38336688
[TBL] [Abstract][Full Text] [Related]
13. Bivalent histone modifications in early embryogenesis.
Vastenhouw NL; Schier AF
Curr Opin Cell Biol; 2012 Jun; 24(3):374-86. PubMed ID: 22513113
[TBL] [Abstract][Full Text] [Related]
14. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
15. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Kwon MJ; Kim SS; Choi YL; Jung HS; Balch C; Kim SH; Song YS; Marquez VE; Nephew KP; Shin YK
Carcinogenesis; 2010 Jun; 31(6):974-83. PubMed ID: 20053926
[TBL] [Abstract][Full Text] [Related]
16. Bimodal quantitative relationships between histone modifications for X-linked and autosomal loci.
Sadreyev RI; Yildirim E; Pinter SF; Lee JT
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6949-54. PubMed ID: 23564346
[TBL] [Abstract][Full Text] [Related]
17. Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos.
Liu X; Wang C; Liu W; Li J; Li C; Kou X; Chen J; Zhao Y; Gao H; Wang H; Zhang Y; Gao Y; Gao S
Nature; 2016 Sep; 537(7621):558-562. PubMed ID: 27626379
[TBL] [Abstract][Full Text] [Related]
18. Bivalent chromatin marks developmental regulatory genes in the mouse embryonic germline in vivo.
Sachs M; Onodera C; Blaschke K; Ebata KT; Song JS; Ramalho-Santos M
Cell Rep; 2013 Jun; 3(6):1777-84. PubMed ID: 23727241
[TBL] [Abstract][Full Text] [Related]
19. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
20. Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells.
Murphy PJ; Cipriany BR; Wallin CB; Ju CY; Szeto K; Hagarman JA; Benitez JJ; Craighead HG; Soloway PD
Proc Natl Acad Sci U S A; 2013 May; 110(19):7772-7. PubMed ID: 23610441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
